The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

Medicare Advantage insurers scored a Thanksgiving gift, as President Trump’s Medicare agency added back a bonus system that ...

Pharmacies will be the canary in the coal mine for the Medicare Drug Price Negotiation Program, writes Sujith Ramachandran.

The U.S. Centers for Medicare & Medicaid Services (CMS) released its delayed and much-anticipated CY 2026 home health final payment rule on Friday, ...

CVS Health (NYSE: CVS) has been a huge outperformer this year. The stock is up about 79% so far in 2025 -- move than five ...

People sometimes miss or skip health checkups because of the cost, the travel or confusion over their health insurance ...

In 2026, Social Security checks are getting bigger. That’s the good news. The bad news, however, is that retirees are likely ...

A seemingly modest $17.90 increase in the standard Medicare Part B premium can quietly erode the Social Security raise many ...

The government overpays Medicare Advantage insurers by $27 billion compared to Original Medicare costs. With open enrollment ending December 7, it's time to evaluate whether those unused extras are ...

Novo Nordisk (NVO) remains a strong buy in the weight loss/diabetes market despite challenges. Read here for an investment ...

Editor: The Nov. 23 editorial about Roseland correctly highlights how continuing efforts can result in improvements in Santa Rosa’s most-needy quadrant ( “Santa Rosa attention to Roseland pays off” ).

Health insurers are pulling out of the Medicare Advantage market. Discover which areas will gain or lose the most, and what to do if your plan is canceled.